Bye bye covid, hello tumors! It'll be approved eventually, most likely, just like nucleoside analogues. Amazing how they don't blink at the approval of these toxic compounds.

Quote:

---

The drug is using the virus’s propensity to mutate against itself by tricking the replication machinery to pump out reproduction errors until the virally infected cell collapses. The last thing the FDA wants to do is approve a drug that brings the rise of a new class of variants. It's unclear if Merck tested patients for new variants that are more likely to rise up in patients who have the longest active infections. Merck isn’t simply going to get a pass on this from the FDA.

---

Wanna bet???